EUA

Bharat Biotech International Ltd (BBIL) on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for its intranasal COVID-19 vaccine, announced Union Health Minister Mansukh Mandaviya. With this, Bharat Biotech's intranasal COVID-19 vaccine will be India's first nasal vaccine for the deadly virus in India. The approval came after the Bharat Biotech completed the third and final trial of the drug, used for… read-more